Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Phio Pharmaceuticals Corp (PHIO)

2.844   -0.206 (-6.75%) 06-01 12:01
Open: 2.92 Pre. Close: 3.05
High: 2.97 Low: 2.78
Volume: 1,493,206 Market Cap: 13M
Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer in the United States. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin and eye. The company also develops Samcyprone, a topical formulation of the small molecule diphenylcyclopropenone for the clearance of common warts; and RXI-231, an sd-rxRNA compound targeting tyrosinase for use as a cosmetic ingredient that enhances the appearance of uneven skin tone and pigmentation. In addition, it develops RXI-109 that reduces the progression of retinal scarring. The company has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phi

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.489 - 6.526 6.526 - 6.559
Low: 2.954 - 2.977 2.977 - 2.998
Close: 3.017 - 3.05 3.05 - 3.08

Technical analysis

as of: 2020-06-01 11:31:31 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.46     One year: 7.57
Support: Support1: 1.76    Support2: 1.46
Resistance: Resistance1: 4.68    Resistance2: 6.48
Pivot: 2.40
Moving Average: MA(5): 2.58     MA(20): 2.38
MA(100): 3.98     MA(250): 11.00
MACD: MACD(12,26): 0.14     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 20.66     %D(3): 28.16
RSI: RSI(14): 63.94
52-week: High: 25.30  Low: 1.60  Change(%): -88.0
Average Vol(K): 3-Month: 139845  10-Days: 616759

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PHIO has closed below upper band by 3.4%. Bollinger Bands are 63.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to PHIO's normal range. The bands have been in this narrow range for 62 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 29 May 2020
Phio Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity - Yahoo Finance

Fri, 29 May 2020
Stock Alert: Phio Pharma Shares Soar 125% - Nasdaq

Mon, 01 Jun 2020
Is It Right Time to Be Bearish on Phio Pharmaceuticals Corp. (NASDAQ:PHIO), First Financial Bancorp. (NASDAQ:FFBC)? - State Reviewer

Mon, 04 May 2020
Phio to Present at Upcoming Medical Meetings and Investor Conference in Spring 2020 - PRNewswire

Tue, 12 May 2020
Phio Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update - Yahoo Finance

Fri, 29 May 2020
50 Stocks Moving In Friday's Mid-Day Session - Benzinga

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5
Shares Float (M) 3
% Held by Insiders 6.76
% Held by Institutions 30.47
Shares Short (K) 60
Shares Short P. Month (K) 4

Stock Financials

EPS -11.267
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.180
Profit Margin
Operating Margin
Return on Assets (ttm) -41.1
Return on Equity (ttm) -77.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.934
Sales Per Share
EBITDA (p.s.) -1.993
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.25
PEG Ratio
Price to Book value 0.68
Price to Sales
Price to Cash Flow -1.51

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.